Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

Stephen Kolek has come a long way since the Padres swiped him from the Mariners in the Rule 5 draft ahead of the 2024 season ...

Martin Huber; President, Chief Executive Officer, Director; Mersana Therapeutics Inc Brian Deschuytner; Chief Financial Officer, Chief Operating Officer, Senior Vice President; Mersana Therapeutics ...

This summer’s busy music schedule at the Shore is without any oversize Atlantic City beach concerts for the second year running. But there’s plenty of action in casino ...

Major League Fishing, the world’s largest tournament-fishing organization, announced today a new partnership with Zenni ...

Belrestotug plus dostarlimab showed no progression-free survival benefit in NSCLC, leading GSK and iTeos to discontinue all ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Research and development expenses were $6.7 million for the first quarter ended March 31, 2025, compared to $10.4 million in ...

The City of Geneva Police Department posted a ‘quick-fact’ sheet to its Facebook page over the weekend which included the ...

Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval "In the first quarter of 2025, we achieved a major milestone for Aquestive with the submission ...